R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T
Abstract
Share and Cite
Kim, J.; Moestue, S.A.; Bathen, T.F.; Kim, E. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T. Tomography 2019, 5, 308-319. https://doi.org/10.18383/j.tom.2019.00015
Kim J, Moestue SA, Bathen TF, Kim E. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T. Tomography. 2019; 5(3):308-319. https://doi.org/10.18383/j.tom.2019.00015
Chicago/Turabian StyleKim, Jana, Siver A. Moestue, Tone F. Bathen, and Eugene Kim. 2019. "R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T" Tomography 5, no. 3: 308-319. https://doi.org/10.18383/j.tom.2019.00015